155 related articles for article (PubMed ID: 38711614)
1. A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy.
Xie W; Zhang Y; Xu Q; Zhong G; Lin J; He H; Du Q; Tan H; Chen M; Wu Z; Deng Y; Han Z; Lu J; Ye J; Zou F; Zhuo Y; Zhong W
Int J Nanomedicine; 2024; 19():3957-3972. PubMed ID: 38711614
[TBL] [Abstract][Full Text] [Related]
2. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.
Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F
J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089
[TBL] [Abstract][Full Text] [Related]
3. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
4. A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy.
Qiang L; Cai Z; Jiang W; Liu J; Tai Z; Li G; Gong C; Gao S; Gao Y
J Nanobiotechnology; 2019 Jul; 17(1):83. PubMed ID: 31291948
[TBL] [Abstract][Full Text] [Related]
5. Hollow mesoporous MnO
He H; Yang Q; Li H; Meng S; Xu Z; Chen X; Sun Z; Jiang B; Li C
Mikrochim Acta; 2021 Mar; 188(4):141. PubMed ID: 33774694
[TBL] [Abstract][Full Text] [Related]
6. An Ellagic Acid Coordinated Copper-Based Nanoplatform for Efficiently Overcoming Cancer Chemoresistance by Cuproptosis and Synergistic Inhibition of Cancer Cell Stemness.
Lu S; Tian H; Li B; Li L; Jiang H; Gao Y; Zheng L; Huang C; Zhou Y; Du Z; Xu J
Small; 2024 Apr; 20(17):e2309215. PubMed ID: 38044295
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Sensitive Biodegradable Nanoparticles of Molecularly Imprinted Polymer-Stabilized Fluorescent Zeolitic Imidazolate Framework-8 for Targeted Imaging and Drug Delivery.
Qin YT; Feng YS; Ma YJ; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24585-24598. PubMed ID: 32390415
[TBL] [Abstract][Full Text] [Related]
8. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
[TBL] [Abstract][Full Text] [Related]
9. A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation.
Xu Q; Wan J; Bie N; Song X; Yang X; Yong T; Zhao Y; Yang X; Gan L
Theranostics; 2018; 8(19):5362-5378. PubMed ID: 30555552
[TBL] [Abstract][Full Text] [Related]
10. Oxygen Self-Sufficient Core-Shell Metal-Organic Framework-Based Smart Nanoplatform for Enhanced Synergistic Chemotherapy and Photodynamic Therapy.
Ren SZ; Wang B; Zhu XH; Zhu D; Liu M; Li SK; Yang YS; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24662-24674. PubMed ID: 32394704
[TBL] [Abstract][Full Text] [Related]
11. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.
Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L
J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114
[TBL] [Abstract][Full Text] [Related]
12. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T
Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587
[TBL] [Abstract][Full Text] [Related]
13. A diselenium-bridged covalent organic framework with pH/GSH/photo-triple-responsiveness for highly controlled drug release toward joint chemo/photothermal/chemodynamic cancer therapy.
Lou H; Chu L; Zhou W; Dou J; Teng X; Tan W; Zhou B
J Mater Chem B; 2022 Oct; 10(39):7955-7966. PubMed ID: 35792081
[TBL] [Abstract][Full Text] [Related]
14. Dual-Responsive and ROS-Augmented Nanoplatform for Chemo/Photodynamic/Chemodynamic Combination Therapy of Triple Negative Breast Cancer.
Chen M; Yang J; Zhou L; Hu X; Wang C; Chai K; Li R; Feng L; Sun Y; Dong C; Shi S
ACS Appl Mater Interfaces; 2022 Jan; 14(1):57-68. PubMed ID: 34935343
[TBL] [Abstract][Full Text] [Related]
15. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging.
He H; Meng S; Li H; Yang Q; Xu Z; Chen X; Sun Z; Jiang B; Li C
Mikrochim Acta; 2021 Apr; 188(5):154. PubMed ID: 33821295
[TBL] [Abstract][Full Text] [Related]
16. A nanoselenium-coating biomimetic cytomembrane nanoplatform for mitochondrial targeted chemotherapy- and chemodynamic therapy through manganese and doxorubicin codelivery.
Xiao J; Yan M; Zhou K; Chen H; Xu Z; Gan Y; Hong B; Tian G; Qian J; Zhang G; Wu Z
J Nanobiotechnology; 2021 Jul; 19(1):227. PubMed ID: 34330298
[TBL] [Abstract][Full Text] [Related]
17. Dual Roles of Metal-Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy.
Zhao H; Li T; Yao C; Gu Z; Liu C; Li J; Yang D
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6034-6042. PubMed ID: 33499584
[TBL] [Abstract][Full Text] [Related]
18. A γ-cyclodextrin-based metal-organic framework embedded with graphene quantum dots and modified with PEGMA via SI-ATRP for anticancer drug delivery and therapy.
Jia Q; Li Z; Guo C; Huang X; Song Y; Zhou N; Wang M; Zhang Z; He L; Du M
Nanoscale; 2019 Nov; 11(43):20956-20967. PubMed ID: 31660562
[TBL] [Abstract][Full Text] [Related]
19. Enhanced reactive oxygen species through direct copper sulfide nanoparticle-doxorubicin complexation.
Li Y; Cupo M; Guo L; Scott J; Chen YT; Yan B; Lu W
Nanotechnology; 2017 Dec; 28(50):505101. PubMed ID: 29076808
[TBL] [Abstract][Full Text] [Related]
20. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
